Skip to main content
TipRanks
Go Ultimate75% OFF

Biogen (BIIB) Drug Pipeline

0 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Biib147Amyotrophic Lateral Sclerosisphase1AndPhase2RecruitingA Study to Learn About the Safety of BIIB147 and Its Effects in Adults With Amyotrophic Lateral Sclerosis (ALS)Sep 28, 2026―
FelzartamabGraves' DiseasePhase IIRecruitingA Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years OldJul 20, 2026
Biib144Healthy VolunteerPhase IRecruitingA Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is Processed in the Body of Healthy Adult Participants Ages 18 to 55 Years Old as Compared to a PlaceboJun 18, 2026
Fingolimod, Dimethyl Fumarate, Diroximel FumarateRelapsing Forms Of Multiple SclerosisPhase IIINot Yet RecruitingA Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)Feb 26, 2026
Sham Procedure, Salanersen, Biib115Muscular Atrophy, SpinalPhase IIIRecruitingA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene AbeparvovecFeb 26, 2026
FelzartamabAntibody-Mediated Rejection, Microvascular InflammationPhase IIIEnrolling By InvitationA Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)Feb 26, 2026
Salanersen, Biib115Spinal Muscular AtrophyPhase IIIRecruitingA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With RisdiplamFeb 26, 2026
OmaveloxoloneHealthy VolunteerPhase ICompletedA Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55Dec 09, 2025
Biib145Healthy VolunteerPhase IRecruitingA Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult ParticipantsNov 04, 2025
TofersenAmyotrophic Lateral SclerosisPhase IVActive Not RecruitingA Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)Oct 31, 2025―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biogen Inc. (MX:BIIB) have in its pipeline
Biogen MX:BIIB is currently developing the following drugs: Biib147, Felzartamab, Biib144, Fingolimod, Dimethyl Fumarate, Diroximel Fumarate, Sham Procedure, Salanersen, Biib115, Salanersen, Biib115, Omaveloxolone, Biib145, Tofersen, Salanersen, Omeprazole, Omaveloxolone, Biib142, Tacrolimus, Felzartamab, Standard Of Care Ist, Litifilimab, Ai, Obi, Pfs, Biib091, Biib122 225 Mg, Moxifloxacin, Biib091, Nusinersen, Thecaflex Drx System, Biib080, [89Zr]Zr-Dfo-Biib080, Biib800, Actemra, Biib059, Moxifloxacin, Omaveloxolone, Omaveloxolone, Efavirenz, Biib091, Drf, Dimethyl Fumarate, Zuranolone, Rta 901, Biib115, Litifilimab, Biib080, Biib122. These drug candidates are in various stages of clinical development as the company works toward FDA approval.